Podcast in English
Text size
Bulgarian National Radio © 2024 All Rights Reserved

Bulgarian is head of work on therapy against Covid-19 in United States

Photo: pitt.edu

A team of American scientists, led by Bulgarian Prof. Dimitar Dimitrov of the University of Pittsburgh, is working on a promising therapy against Covdi-19. It is based on the isolation of antibodies that block the virus.

In a special interview for the Bulgarian National Radio, Prof. Dimitrov explained the principle of action of the therapy: “Our antibody binds to the virus very strongly and prevents the virus from entering the cells. When there is an antibody present, either before infection or after infection, it binds to the virus and it can no longer continue to infect cells. This means it can be used both to prevent infection and to treat already infected people.




Последвайте ни и в Google News Showcase, за да научите най-важното от деня!
Listen to the daily news from Bulgaria presented in "Bulgaria Today" podcast, available in Spotify.

More from category

Snowfall in the mountains on Christmas Eve

On Tuesday it will be cloudy, with rainfalls in many places. In the high fields of the western regions of Bulgaria it will snow. In the eastern regions the precipitation will be significant. In the western and central regions the..

published on 12/23/24 6:55 PM

2.5 billion euros allocated for construction of second Danube bridge between Ruse and Giurgiu

The construction of a new Danube bridge near Ruse may begin in 2026, as European funding totalling 2.5 billion euros has been provided, the city's regional governor, Dragomir Draganov reported. The new bridge over the..

published on 12/23/24 4:02 PM
Dimitar Glavchev

Bulgaria will fulfil the last criterion for entering the eurozone in mid-January

Around mid-January, we are expected to fulfil the last criterion for the eurozone, which will allow us to submit the convergence reports to the European Central Bank and the European Commission, caretaker Prime Minister Dimitar..

published on 12/23/24 2:40 PM